NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Johnson Chemical Pharmaceutical Works Co. Ltd (TWO: 4747)
4747 Technical Analysis
5
As on 1st Apr 2025 4747 STOCK Price closed @ 70.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 78.75 & Strong Sell for SHORT-TERM with Stoploss of 89.87 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4747STOCK Price
Open | 72.80 | Change | Price | % |
High | 72.80 | 1 Day | -2.50 | -3.43 |
Low | 70.00 | 1 Week | -4.70 | -6.27 |
Close | 70.30 | 1 Month | -0.60 | -0.85 |
Volume | 163199 | 1 Year | -25.30 | -26.46 |
52 Week High 98.00 | 52 Week Low 65.00 |
TWO Taiwan Most Active Stocks
4541 | 53.30 | 9.90% |
4303 | 82.70 | 2.10% |
4931 | 83.00 | -0.95% |
3264 | 73.70 | -0.14% |
1815 | 30.15 | -0.17% |
3163 | 171.50 | -0.58% |
6148 | 47.30 | 1.18% |
1569 | 70.60 | -4.85% |
4979 | 164.50 | -2.37% |
8096 | 63.00 | 1.61% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
4747 Daily Charts |
4747 Intraday Charts |
Whats New @ Bazaartrend |
4747 Free Analysis |
|
4747 Important Levels Intraday
RESISTANCE | 75.70 |
RESISTANCE | 73.97 |
RESISTANCE | 72.90 |
RESISTANCE | 71.83 |
SUPPORT | 68.77 |
SUPPORT | 67.70 |
SUPPORT | 66.63 |
SUPPORT | 64.90 |
4747 Forecast April 2025
4th UP Forecast | 99.4 |
3rd UP Forecast | 90.07 |
2nd UP Forecast | 84.3 |
1st UP Forecast | 78.53 |
1st DOWN Forecast | 62.07 |
2nd DOWN Forecast | 56.3 |
3rd DOWN Forecast | 50.53 |
4th DOWN Forecast | 41.2 |
4747 Weekly Forecast
4th UP Forecast | 79.16 |
3rd UP Forecast | 76.32 |
2nd UP Forecast | 74.56 |
1st UP Forecast | 72.81 |
1st DOWN Forecast | 67.79 |
2nd DOWN Forecast | 66.04 |
3rd DOWN Forecast | 64.28 |
4th DOWN Forecast | 61.44 |
4747 Forecast2025
4th UP Forecast | 137.75 |
3rd UP Forecast | 116.12 |
2nd UP Forecast | 102.75 |
1st UP Forecast | 89.38 |
1st DOWN Forecast | 51.23 |
2nd DOWN Forecast | 37.86 |
3rd DOWN Forecast | 24.49 |
4th DOWN Forecast | 2.85 |
Johnson Chemical Pharmaceutical Works Co. Ltd ( TWO Taiwan Symbol : 4747 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4747 Other Details
Segment | EQ | |
Market Capital | 1065674496.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
4747 Address
![]() |
4747 Latest News
4747 Business Profile
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures and sells pharmaceutical materials and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. The company was incorporated in 1966 and is based in New Taipei City, Taiwan. Address: No. 77,79 Sanhe Road, New Taipei City, Taiwan, 241
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service